Wealth Advisory Solutions’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,944
Closed -$310K 129
2024
Q2
$310K Sell
3,944
-391
-9% -$32.1K 0.08% 101
2024
Q1
$378K Sell
4,335
-830
-16% -$70.8K 0.1% 95
2023
Q4
$425K Sell
5,165
-10,337
-67% -$788K 0.15% 61
2023
Q3
$1.24M Buy
15,502
+5,293
+52% +$443K 0.24% 63
2023
Q2
$899K Sell
10,209
-1,063
-9% -$91.5K 0.24% 64
2023
Q1
$909K Buy
11,272
+8,088
+254% +$659K 0.24% 70
2022
Q4
$247K Sell
3,184
-52,078
-94% -$4.22M 0.07% 116
2022
Q3
$4.46M Sell
55,262
-7,458
-12% -$670K 1.23% 20
2022
Q2
$5.63M Buy
62,720
+12,753
+26% +$1.29M 1.39% 18
2022
Q1
$5.54M Buy
+49,967
New +$5.28M 1.15% 27

Other funds holding MDT

Wealth Advisory Solutions's MDT Position: Q3 2024 in Review

Wealth Advisory Solutions sold out of Medtronic (MDT) in Q3 2024, closing a stake of 3,944 shares — an estimated $310K sold.

Wealth Advisory Solutions first reported a position in MDT in Q1 2022 and held it in 10 quarters. The position peaked at $5.63M in Q2 2022. 2,063 funds tracked by Wall St. Rank hold MDT as of Q3 2024.

  • Wealth Advisory Solutions reported no remaining Medtronic position as of Q3 2024 after selling out during the quarter.
  • Wealth Advisory Solutions sold 3,944 Medtronic shares in Q3 2024, an estimated $310K.
  • Wealth Advisory Solutions first reported a position in Medtronic in Q1 2022 and held it in 10 quarters.
  • Wealth Advisory Solutions's Medtronic position peaked at $5.63M in Q2 2022.
  • 2,063 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.

Based on Wealth Advisory Solutions's 13F filing for Q3 2024, filed 21 Oct 2024.